Heart Rhythm Society, April 24-27, San Diego, CA
Booth #735
At iRhythm, we recognize the multifaceted challenges in healthcare and share your dedication to enhancing outcomes across diverse communities and care environments. We're thrilled to join the Hearth Rhythm community to exchange ideas, insights, and innovations that shape the future of technology-driven, patient-focused care.
Let’s start a conversation—and better yet, let’s collaborate. Together, we can deliver improved care to more people.
The iRhythm service features Zio ECG monitors – a comprehensive approach to cardiac monitoring. Easy-to-wear monitors.1-3 Outstanding patient compliance.4-6 Exceptional accuracy.7-9 With our end-to-end service, we've completely changed the world of cardiac monitoring.10-15
Exhibition hours - iRhythm Booth 735
Friday, April 25- 10:00 am – 5:30 pm
Saturday, April 26- 9:00 am – 5:00 pm
Sunday, April 27- 8:30 am- 11:30 am
Sponsored by iRhythm Technologies, inc.
This program is not part of Heart Rhythm 2025 as planned by the Heart Rhythm Program Committee. This event is neither sponsored nor endorsed by the Heart Rhythm Society. This event does not qualify for accredited continuing education (ACE) credit.
Abstracts Presented at #HRS2025
Featured Poster Session
Digital engagement with a patient smartphone app is associated with increased symptom reporting and symptom-rhythm correlation in patients undergoing ambulatory cardiac monitoring
Presented by: Eric Barnhill, PhD, Lead Research Engineer iRhythm Technologies
Session Title: PO-499617 Featured Poster Session
Session Date: April 24, 2025 from 5:00 PM to 6:30 PM
Location: Sails Pavillon
Regular Poster Session
Assessment of Variation in Ambulatory Cardiac Monitoring: Real-World Evidence of Commercially Insured Beneficiaries
Presented by: Pierantonio Russo, MD, FCPP, FAAP, STS, Chief Medical Officer Eversana
Session Title: PO-499631 Poster Session V
Session Date: April 26, 2025 from 12:00 PM to 2:00 PM
Location: Abstract Pavillion
1. Battisti et al. Abstract 4141717: Feasibility of point-of-wear patient satisfaction surveys to validate patient-centered product enhancements: results from over 300,000 patients for long-term ambulatory cardiac monitoring. Circulation. 2024;150:A4141717. doi:10.1161/circ.150.suppl_1.4141717. https://www.ahajournals.org/doi/abs/10.1161/circ.150.suppl_1.4141717
2. Data on file. iRhythm Technologies, 2024
3. Based on the US market data.
4. Data on file. iRhythm Technologies, 2022.
5. Based on the US data.
6. Zio service provides continuous, uninterrupted recording and a comprehensive end-of-wear report.
7. Data on file. iRhythm Technologies, 2023.
8. Based on the US market data using Zio ECG monitors.
9. Zio service provides continuous, uninterrupted recording and a comprehensive end-of-wear report.
10. Reynolds et al. Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries. Am Heart J. 2024;269:25–34. https://doi.org/10.1016/j.ahj.2023.12.002
11. A specified arrhythmia refers to an arrhythmia encounter diagnosis as per Hierarchical Condition Categories (HCC) 96.
12. Based on previous generation Zio XT device data. Zio monitor utilizes the same operating principles and ECG algorithm. Additional data on file.
13. Zio LTCM service refers to Zio XT and Zio monitor service.
14. Contraindications: Do not use the Zio monitor for critical care patients or for patients with symptomatic episodes where instance variations in cardiac performance could result in immediate danger to the patients or when real-time or in-patient monitoring should be prescribed. (Refer to the Zio monitor Instructions for Use for the full list of contraindications.)
15. Zio monitor and ZEUS are Japan PMDA approved.
WEB0193.01